Skip to main content

Table 2 Effect of agaro-oligosaccharides on MDA activity in different organs of CCl4 induced rats a

From: Antioxidant activity and hepatoprotective potential of agaro-oligosaccharides in vitro and in vivo

Groups

Liver (nmol/mg prot)

Heart (nmol/mg prot)

Serum (nmol/ml)

Normal control

2.75 ± 0.51

0.56 ± 0.08

4.20 ± 0.22

CCl4 control

4.62 ± 0.77#

0.68 ± 0.05

4.44 ± 0.64

Vitamin C

2.59 ± 0.02*

0.67 ± 0.11

3.53 ± 0.74

G4 (200 mg/kg)

3.45 ± 0.77

0.54 ± 0.11

3.33 ± 0.11

G5 (400 mg/kg)

2.71 ± 0.18*

0.53 ± 0.14

3.36 ± 0.63

G6 (600 mg/kg)

2.99 ± 0.47

0.45 ± 0.02

2.82 ± 0.66

  1. a n = 8. Each value represents the mean ± SD.
  2. Significant values: *P < 0.05 (vs CCl4 group); #P < 0.05 (vs Normal group).
  3. G4, G5 and G6: group 4, 5, 6 which administrated with sample of 200 mg/kg, 400 mg/kg and 600 mg/kg, respectively.